Baird Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $84.1M | Sell |
167,777
-39,226
| -19% | -$18.8M | 0.12% | 124 |
|
|
2026
Q1 | $102M | Sell |
207,003
-20,537
| -9% | -$11.1M | 0.16% | 97 |
|
|
2025
Q4 | $132M | Buy |
227,540
+19,878
| +10% | +$11.2M | 0.21% | 82 |
|
|
2025
Q3 | $101M | Buy |
207,662
+7,925
| +4% | +$3.69M | 0.16% | 102 |
|
|
2025
Q2 | $81M | Sell |
199,737
-13,074
| -6% | -$5.47M | 0.14% | 119 |
|
|
2025
Q1 | $106M | Sell |
212,811
-976
| -0.5% | -$529K | 0.2% | 94 |
|
|
2024
Q4 | $111M | Sell |
213,787
-955
| -0.4% | -$525K | 0.21% | 90 |
|
|
2024
Q3 | $133M | Sell |
214,742
-5,012
| -2% | -$2.97M | 0.26% | 78 |
|
|
2024
Q2 | $122M | Buy |
219,754
+13,285
| +6% | +$7.61M | 0.25% | 78 |
|
|
2024
Q1 | $120M | Buy |
206,469
+1,796
| +0.9% | +$1.01M | 0.25% | 85 |
|
|
2023
Q4 | $109M | Buy |
204,673
+73,984
| +57% | +$35.8M | 0.25% | 91 |
|
|
2023
Q3 | $66.2M | Sell |
130,689
-714
| -0.5% | -$380K | 0.18% | 129 |
|
|
2023
Q2 | $68.6M | Sell |
131,403
-67,895
| -34% | -$36.6M | 0.18% | 135 |
|
|
2023
Q1 | $115M | Buy |
199,298
+1,807
| +0.9% | +$1.02M | 0.28% | 71 |
|
|
2022
Q4 | $109M | Sell |
197,491
-2,723
| -1% | -$1.44M | 0.29% | 69 |
|
|
2022
Q3 | $102M | Buy |
200,214
+15,868
| +9% | +$8.88M | 0.3% | 70 |
|
|
2022
Q2 | $100M | Buy |
184,346
+3,015
| +2% | +$1.66M | 0.28% | 78 |
|
|
2022
Q1 | $107M | Buy |
181,331
+643
| +0.4% | +$369K | 0.26% | 77 |
|
|
2021
Q4 | $121M | Buy |
180,688
+4,766
| +3% | +$2.98M | 0.28% | 76 |
|
|
2021
Q3 | $101M | Sell |
175,922
-821
| -0.5% | -$451K | 0.26% | 91 |
|
|
2021
Q2 | $89.2M | Buy |
176,743
+501
| +0.3% | +$236K | 0.23% | 103 |
|
|
2021
Q1 | $80.4M | Buy |
176,242
+9,109
| +5% | +$4.35M | 0.23% | 108 |
|
|
2020
Q4 | $77.8M | Buy |
167,133
+8,041
| +5% | +$3.77M | 0.23% | 112 |
|
|
2020
Q3 | $70.2M | Buy |
159,092
+6,290
| +4% | +$2.6M | 0.24% | 103 |
|
|
2020
Q2 | $55.4M | Buy |
152,802
+26,775
| +21% | +$8.97M | 0.21% | 130 |
|
|
2020
Q1 | $35.7M | Sell |
126,027
-7,266
| -5% | -$2.29M | 0.16% | 160 |
|
|
2019
Q4 | $43.3M | Buy |
133,293
+9,453
| +8% | +$2.87M | 0.16% | 161 |
|
|
2019
Q3 | $36.1M | Buy |
123,840
+40,711
| +49% | +$11.7M | 0.14% | 178 |
|
|
2019
Q2 | $24.4M | Buy |
83,129
+7,837
| +10% | +$2.16M | 0.09% | 225 |
|
|
2019
Q1 | $20.6M | Sell |
75,292
-412
| -0.5% | -$103K | 0.12% | 208 |
|
|
2018
Q4 | $16.9M | Buy |
75,704
+8,501
| +13% | +$1.99M | 0.12% | 216 |
|
|
2018
Q3 | $16.7M | Buy |
67,203
+2,102
| +3% | +$484K | 0.1% | 227 |
|
|
2018
Q2 | $13.5M | Buy |
65,101
+2,282
| +4% | +$484K | 0.09% | 250 |
|
|
2018
Q1 | $13M | Sell |
62,819
-297
| -0.5% | -$62.3K | 0.09% | 247 |
|
|
2017
Q4 | $12M | Buy |
63,116
+660
| +1% | +$126K | 0.08% | 248 |
|
|
2017
Q3 | $11.8M | Sell |
62,456
-2,910
| -4% | -$527K | 0.09% | 239 |
|
|
2017
Q2 | $11.4M | Buy |
65,366
+42
| +0.1% | +$7.05K | 0.09% | 239 |
|
|
2017
Q1 | $10M | Buy |
65,324
+11,610
| +22% | +$1.77M | 0.08% | 251 |
|
|
2016
Q4 | $7.58M | Sell |
53,714
-5,905
| -10% | -$871K | 0.07% | 289 |
|
|
2016
Q3 | $9.48M | Sell |
59,619
-161
| -0.3% | -$24.8K | 0.08% | 246 |
|
|
2016
Q2 | $8.99M | Buy |
59,780
+174
| +0.3% | +$25.7K | 0.08% | 250 |
|
|
2016
Q1 | $8.44M | Buy |
59,606
+3,993
| +7% | +$535K | 0.08% | 254 |
|
|
2015
Q4 | $7.89M | Sell |
55,613
-3,842
| -6% | -$512K | 0.08% | 257 |
|
|
2015
Q3 | $7.27M | Buy |
59,455
+4,956
| +9% | +$646K | 0.08% | 255 |
|
|
2015
Q2 | $7.07M | Buy |
+54,499
| New | +$7.1M | 0.07% | 268 |
|
Other funds holding TMO
Baird Financial Group's TMO Position: Q2 2026 in Review
Baird Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, selling an estimated $18.8M and leaving 167,777 shares worth $84.1M. The position accounts for 0.12% of the portfolio, ranked #124.
Baird Financial Group first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $133M in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Baird Financial Group held 167,777 shares of Thermo Fisher Scientific worth $84.1M as of Q2 2026.
- Baird Financial Group sold 39,226 Thermo Fisher Scientific shares in Q2 2026, an estimated $18.8M.
- Thermo Fisher Scientific made up 0.12% of Baird Financial Group's portfolio in Q2 2026, its #124 holding.
- Baird Financial Group first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
- Baird Financial Group's Thermo Fisher Scientific position peaked at $133M in Q3 2024.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.